Comparison between Dr Lalchandani Labs IPO and E2E Networks IPO.
Dr Lalchandani Labs IPO is a SME Fixed Price IPO proposed to list at BSE SME while E2E Networks IPO is a SME Fixed Price proposed to list at NSE SME.
| Dr Lalchandani Labs IPO | E2E Networks IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Navigant Corporate Advisors Ltd. | Holani Consultants Pvt.Ltd. |
| Registrar | Cameo Corporate Services Ltd. | MUFG Intime India Pvt.Ltd. |
| Market Maker | NNM Securities Pvt.Ltd. | Choice Equity Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Dr Lalchandani Labs IPO is up to ₹3.98 Cr whereas the issue size of the E2E Networks IPO is up to ₹20.88 Cr. The final issue price of Dr Lalchandani Labs IPO is ₹30.00 per share and of E2E Networks IPO is ₹57.00 per share.
| Dr Lalchandani Labs IPO | E2E Networks IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹30.00 per share | ₹57.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 4000 shares | 2000 shares |
| Fresh Issue Size | 13,28,000 shares | 25,56,000 shares |
| Fresh Issue Size (Amount) | up to ₹3.98 Cr | up to ₹14.57 Cr |
| OFS Issue Size | 0 shares | 11,08,000 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹6.32 Cr |
| Issue Size Total | 13,28,000 shares | 36,64,000 shares |
| Issue Size Total (Amount) | up to ₹3.98 Cr | up to ₹20.88 Cr |
Dr Lalchandani Labs IPO opens on Apr 25, 2018, while E2E Networks IPO opens on May 03, 2018. The closing date of Dr Lalchandani Labs IPO and E2E Networks IPO is Apr 27, 2018, and May 07, 2018, respectively.
| Dr Lalchandani Labs IPO | E2E Networks IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Apr 25, 2018 | May 03, 2018 |
| Issue Close | Apr 27, 2018 | May 07, 2018 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | May 09, 2018 | May 15, 2018 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Dr Lalchandani Labs IPO P/E ratio is , as compared to E2E Networks IPO P/E ratio of .
| Dr Lalchandani Labs IPO | E2E Networks IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | ||||||
| Promoter Shareholding (Post-Issue) | ||||||
| P/E Ratio | ||||||
| Market Cap | ₹13.00 Cr. | ₹81.20 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Dr Lalchandani Labs IPO Retail Individual Investors (RII) are offered 6,64,000 shares while in E2E Networks IPO retail investors are offered 6,64,000 shares. Qualified Institutional Buyers (QIB) are offered in Dr Lalchandani Labs IPO and in E2E Networks IPO.
| Dr Lalchandani Labs IPO | E2E Networks IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 72,000 shares | 1,94,000 shares |
| QIB | ||
| NII | 6,64,000 shares | 18,32,000 shares |
| RII | 6,64,000 shares | 18,32,000 shares |
| Employee | ||
| Others | ||
| Total | 13,28,000 shares | 36,64,000 shares |
Dr Lalchandani Labs IPO subscribed 4.63x in total, whereas E2E Networks IPO subscribed 72.11x.
| Dr Lalchandani Labs IPO | E2E Networks IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 3.13x | 130.82x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 6.13x | 13.39x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 4.63x | 72.11x |
